p63 and IRF6: Brothers in arms against cleft palate

Journal of Clinical Investigation

Volumn 120, Issue 5, 2010, Pages 1386-1389

  Gritli Linde, Amel ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 6; PROTEASOME; PROTEIN P63; TRANSFORMING GROWTH FACTOR BETA;

AEC SYNDROME; CELL DIFFERENTIATION; CELL PROLIFERATION; CLEFT PALATE; EEC SYNDROME; ENZYME DEGRADATION; EPITHELIUM CELL; GENE MUTATION; HUMAN; NONHUMAN; NOTE; ORGANOGENESIS; PALATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLEFT PALATE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERFERON REGULATORY FACTORS; MEMBRANE PROTEINS; MICE; MUTATION; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANS-ACTIVATORS; UBIQUITIN;

EID: 77951862285     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI42821     Document Type: Note

References (20)

1. Rinne T, Bruner HG, van Bokhoven H. P63-associated disorders. Cell Cycle. 2007;6(3):262-268.
2. Kondo S, et al. Mutations in IRF6 cause van der Woude and popliteal pterygium syndromes. Nat Genet. 2002;32(2):285-289.
3. Gritli-Linde A. The etiopathogenesis of cleft lip and cleft palate: Usefulness and caveats of mouse models. Curr Top Dev Biol. 2008;84:37-138.
4. Mikkola ML. P63 in skin appendage development. Cell Cycle. 2007;6(3):285-290.
5. Thomason HA, Dixon MJ, Dixon J. Facial clefting in Tp63 deficient mice result from altered Bmp4, Fgf8 and Shh signaling. Dev Biol. 2008;321(1):273-282.
6. Ingraham CR, et al. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet. 2006;38(11):1335-1340.
7. Richardson RJ, et al. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet. 2006;38(11):1329-1334.
8. Bailey CM, Hendrix MJC. IRF6 in development and disease: A mediator of quiescence and differentiation. Cell Cycle. 2008;7(13):1925-1930.
9. Moretti F, et al. A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J Clin Invest. 2010;120(5):1570-1577.
10. Thomason HA, et al. Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J Clin Invest. 2010;120(5):1561-1569.
11. Rahimov F, et al. Disruption of an AP-2α binding site in an IRF6 enhancer is strongly associated with cleft lip. Nat Genet. 2008;40(11):1341- 1347.
12. Richardson RJ, Dixon J, Jiang R, Dixon MJ. Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence. Hum Mol Genet. 2009;18(14):2632-2642.
13. Xu X, et al. Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-β/BMP signaling during tooth and palate development. Dev Cell. 2008;15(2):322-329.
14. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol. 2003;23(7):2264-2276.
15. Adorno M, et al. A mutant-p53/Smad complex opposes p63 to empower Tgfβ-induced metastasis. Cell. 2009;137(1):87-98.
16. Ghioni P, et al. The protein stability and transcriptional activity of p63α are regulated by SUMO-1 conjugation. Cell Cycle. 2005;4(1):183-190. (Pubitemid 41038949)
17. Rossi M, et al. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci U S A. 2006;103(34):12753-12758. (Pubitemid 44298633)
18. Li Y, Zhou Z, Chen C. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ. 2008;15(12):1941-1951.
19. Little HJ, et al. Missense mutations that cause van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6. Hum Mol Genet. 2009;18(3):535-545.
20. Fomenkov A, et al. RACK1 and Stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle. 2004;3(10):1285-1295. (Pubitemid 40268612)